Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruiting across multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Endometrial Cancer
• Head and Neck Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Testicular Cancer

Drugs mentioned

• GV20-0251

Snippet

Sponsor: West China Hospital | Conditions: HCC - Hepatocellular Carcinoma, Cholangiocarcinoma | Phase 1 | Status: RECRUITING